Canada markets closed
LATEST UPDATE

NO WEEKLY BRIEF NEWSLETTER FOR THE WEEKEND OF OCT. 16-17

We are taking a short break, but we'll be back next week. Stay tuned!

Radient Technologies Inc. (RTI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.05500.0000 (0.00%)
At close: 3:53PM EDT
Sign in to post a message.
  • N
    ND
    One product sold out on OCS. I think price plays a big role here. Now it is time for the feedback on the quality.
  • J
    John
    months of waiting, 2 earnings reports later and we have a total of 348 dollars exchanged today
  • T
    Tony
    Good start according to quarterly revenue report. Looking forward to the outcome of the Tuna and PBR negotiations/transactions. I believe once RTI has full control, the revenue will follow. Till the end of October, then. Should be just in time for the next quarterly report. The comment about promising 'frequent' communication was also encouraging. Buzz builds interest, followed by stock price. Might also be time for a name change if radiant tech is truly on the back burner. Could be a bit of smell attached to the RTI name. Name should reflect what the company is today. My vote is for 'Phoenix'.
  • T
    Tony
    So . . . . what's up with the deal with Shopper's Drug Mart? Maybe there has been something said somewhere that I missed? Not a user of the product myself, so are they no longer producing what Shopper's sells? Would appreciate anyone with info as to the BIOU product supposedly being sold by Shoppers, more for my curiosity than any other reason. Seemed like a big deal when it was announced and Shoppers is a big chain. Seemed like a potential income channel
  • y
    ybd
    Collaboration between Tunaaaaroom and Viridian Cannabis should mean more $$$ for Radient...

    https://www.instagram.com/p/CUqOWjtlPa4/?utm_medium=copy_link
  • T
    TomD
    Regarding margins; how about this take. The price per SKU coupled with quality is virtually unbeatable. Products are flying off the shelves due to the Tuna name. I see many other inferior products at higher prices that eventually go to the Price Slash bin. They aren't moving. Volume should generate cash flow and we can corner a chunk of the market. The MD and A did state they have a backlog of orders. Just my two cents.
  • M
    Mason
    High grade supply and RTI look about ready to fire up some rather large Butane machines?

    https://instagram.com/stories/highgrade.supply/2679391338191318199?utm_medium=share_sheet
  • D
    D
    Today’s the beginning a beautiful day!
    Radient quarterly results indicate a 1600% increase in revenue over same quarter last year! With significant drop in operating costs by 55%!
    Time to grab some extremely cheap shares now.
    https://stockhouse.com/news/press-releases/2021/10/06/radient-technologies-inc-announces-q1-2022-financial-results?fbclid=IwAR0wghXCXOjrZhGtcr_y1kKLqEGhT2jT1hFJCEL1eqjC8WDrpSdoL5cnOjU
    Radient Technologies Inc. Announces Q1 2022 Financial Results
    stockhouse.com
  • J
    John
    Just read the MD and A…not much money was made which was to be expected but IMO the results coming out on or before October 5th will give us a clearer understanding of the future. Aside from not making much money, the only thing disappointing in the MD and A is that the founder of Dreamy CBD passed away so that has been put on pause. This next update will determine our future…good luck to all
  • T
    The Doc
    Nobody look at the revenue vs cogs? It cost them 683k to make 750k in revenue. This reflects the fact that there is no money in cannabis, those margins are hoooorible. Tuna train hahahah wha?
  • S
    Sandy and Debbie
    In my opinion, there is no difference between Theranos and Radient.

    Elizabeth Holmes (ex CEO and founder of Theranos) and Dennis (ex CEO of Radient) both falsified company information and pumped the stock when in reality there was no substance or merit to such claims. It was intentional to mislead investors.

    RDDTF buying product from ACB made no sense. In particular the mass volume bought from ACB did not align with Radient plant capacity to process. That is obvious. My next issue, the volume purchased by Radient from ACB could not be processed in a timely manner.

    Dennis should go to jail but since this company is Canadian, the laws are different.

    Just my observation and views on RDDTF
  • J
    John
    excellent. all that good news setting in now. great to be sub .04
  • T
    TomD
    Not putting too much faith in these financials in regards to revenue. We lost Premium 5 early in the quarter and Tuna products were just coming out in Saskatchewan only. Maybe we'll get some juicy news to overcome the revenue lag. The following quarter being released October 5 (hopefully) should be much better. I found a pile of TRX stuff for sale on Alberta Cannabis as well as some new Atomic Eh live resin vapes at really low prices. We seem to really have a foot in the door finally. TRX in Ontario was almost sold out of everything before the OCS listed SKUs. I didn't realize the dispensaries could purchase the SKUs before they were listed on the OCS site. They have first dibs which makes sense. Should be a very interesting fall.
  • T
    Thomas
    folks here - I was in this wanna be years ago..It never will amount to anything substantial. Its not trading because its not worth trading anymore IMO Its not even a good swing trade.
  • C
    Coco Higgins
    I drove by the facility and there was a pizza delivery driver there. It is going to be a late night for the team!
  • J
    John
    stellar performance. the 6 month wait on numbers was worth it
  • J
    John
    fins tonight, tomorrow morning or night?
  • J
    John
    Radient employees quoted in the filing said there was no business reason for the cannabis processor to buy $21.7 million worth of cannabis from Aurora. One former employee alleged Radient’s operations were too small to process such a large amount of cannabis in a reasonable amount of time; another former employee said it made “no sense” for Radient to make the purchase because the company was having trouble paying its ongoing operating expenses, and its extraction technology was still in a testing phase.